SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-047361
Filing Date
2019-10-04
Accepted
2019-10-04 16:10:34
Documents
3
Period of Report
2019-10-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv530683_8k.htm 8-K 18202
2 EXHIBIT 99.1 tv530683_ex99-1.htm EX-99.1 54737
3 GRAPHIC tv530683_logo.jpg GRAPHIC 14916
  Complete submission text file 0001144204-19-047361.txt   94854
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10113 | Film No.: 191138722
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences